Molecular mechanisms of anti-angiogenic effect of curcumin

Molecular Cloning: A Laboratory Manual

2001 • 133,517 citations

Molecular cloning: A laboratory manual

1990 • 85,659 citations

The Hallmarks of Cancer

2000 • 27,569 citations

Angiogenesis in cancer, vascular, rheumatoid and other disease

1995 • 7,717 citations

Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

1996 • 6,878 citations

Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis

1997 • 3,470 citations

The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing

1991 • 1,991 citations

Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning

1996 • 1,969 citations

Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation

1995 • 1,808 citations

Pharmacology ofCurcuma longa

1991 • 1,684 citations

Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)

1995 • 1,352 citations

Tumor angiogenesis: past, present and the near future

2000 • 973 citations

Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, Angiopoietins, and ephrins in vascular development

1999 • 795 citations

Genistein, a dietary-derived inhibitor of in vitro angiogenesis.

1993 • 777 citations

Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound.

1995 • 682 citations

Turmeric — chemistry, technology, and quality

1980 • 571 citations

Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice.

1994 • 550 citations

How Tumors Become Angiogenic

1996 • 514 citations

Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells

1999 • 490 citations

Curcumin Is an In Vivo Inhibitor of Angiogenesis

1998 • 406 citations

Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin

1998 • 399 citations

Role of Vascular Endothelial Growth Factor in Ovarian Cancer

1998 • 396 citations

Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells.

1991 • 381 citations

Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2

1998 • 376 citations

Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines

1996 • 279 citations

Curcuminoids Inhibit the Angiogenic Response Stimulated by Fibroblast Growth Factor-2, Including Expression of Matrix Metalloproteinase Gelatinase B

2000 • 273 citations

Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth.

1997 • 257 citations

Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon

1993 • 218 citations

Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetateinduced tumor promotion

1995 • 194 citations

Strategy and planning for chemopreventive drug development: Clinical development plans II

1996 • 192 citations

Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin

1991 • 186 citations

Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin.

1998 • 164 citations

Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases.

2000 • 149 citations

Mechanisms of Curcumin-Induced Apoptosis of Ehrlich's Ascites Carcinoma Cells

2001 • 143 citations

Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.

1999 • 139 citations

Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin

1995 • 137 citations

Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis

1994 • 115 citations

Bioactive phytochemicals with emphasis on dietary practices.

1998 • 106 citations

Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors.

1998 • 102 citations

Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.

1998 • 86 citations

Hypoxia and vascular endothelial growth factor selectively upregulate angiopoietin-2 in bovine microvascular endothelial cells.

2001 • 69 citations

Effect of dietary curcumin and ascorbyl palmitate on azoxymethanol-induced colonic epithelial cell proliferation and focal areas of dysplasia

1992 • 67 citations

Role of endothelial cell survival and death signals in angiogenesis.

1999 • 63 citations

Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes

2000 • 61 citations

Tumor angiogenesis: the pivotal role of vascular endothelial growth factor

1996 • 52 citations

Suppression of ascites formation and re-accumulation associated with human ovarian cancer by an anti-VPF monoclonal antibody in vivo.

2000 • 44 citations

VEGF/Flk-1 Interaction, a Requirement for Malignant Ascites Recurrence

2000 • 36 citations

Nuclear Factor-κB and cAMP Response Element Binding Protein Mediate Opposite Transcriptional Effects on the Flk-1/KDR Gene Promoter

2000 • 31 citations

Selective Induction of Apoptosis in Myeloid Leukemic Cell Lines by Monoacetone Glucose-3 Butyrate

1994 • 25 citations

Molecular mechanism of action of butyric acid in Ehrlich Ascites Tumor cells

1999 • 14 citations

Novel Antibodies Directed Against the Extracellular Domain of the Human VEGF-Receptor Type II

1997 • 9 citations